Estimating Cost Savings from Early Cancer Diagnosis
We estimate treatment cost-savings from early cancer diagnosis. For breast, lung, prostate and colorectal cancers and melanoma, which account for more than 50% of new incidences projected in 2017, we combine published cancer treatment cost estimates by stage with incidence rates by stage at diagnosi...
Main Authors: | Zura Kakushadze, Rakesh Raghubanshi, Willie Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | Data |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5729/2/3/30 |
Similar Items
-
Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study
by: Hla-Hla Thein, et al.
Published: (2018-06-01) -
COMPLEXITY OF EARLY DIAGNOSIS AND TREATMENT OF RHEUMATIC DISEASES
by: M. V. Sklyanova, et al.
Published: (2012-09-01) -
Blount's disease: The importance of early diagnosis and early treatment
by: Ioannis Delniotis, et al.
Published: (2019-07-01) -
Treatment of dissociative disorders and reported changes in inpatient and outpatient cost estimates
by: Amie C. Myrick, et al.
Published: (2017-01-01) -
Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome
by: Céline Bar, et al.
Published: (2017-06-01)